ORBIMED ADVISORS LLC Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$5.2B
Holdings
115
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (115 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | BCABBIOATLA INC | 332,372 | $2.7B | 52.46% | |
| 102 | APLTAPPLIED THERAPEUTICS INC | 3,050,921 | $2.3B | 44.36% | |
| 103 | TARAPROTARA THERAPEUTICS INC | 830,641 | $2.2B | 42.59% | |
| 104 | —GRAYBUG VISION INC | 4,163,347 | $2.1B | 39.82% | |
| 105 | GDRXGOODRX HLDGS INC | 387,567 | $1.8B | 34.55% | |
| 106 | EYPTEYEPOINT PHARMACEUTICALS INC | 487,642 | $1.7B | 32.65% | |
| 107 | CYBNEURCYBIN INC | 5,386,299 | $1.7B | 31.60% | |
| 108 | PYXSPYXIS ONCOLOGY INC | 848,252 | $1.1B | 21.74% | |
| 109 | —HARPOON THERAPEUTICS INC | 1,516,496 | $1.1B | 21.05% | |
| 110 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $1.1B | 20.79% | |
| 111 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 771,059 | $1.0B | 19.18% | |
| 112 | EPIEURESSA PHARMA INC | 365,300 | $920.6M | 17.61% | |
| 113 | MACKEURMERRIMACK PHARMACEUTICALS IN | 73,600 | $843.5M | 16.14% | |
| 114 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,797,221 | $808.6M | 15.47% | |
| 115 | PHGEBIOMX INC | 2,813,489 | $525.3M | 10.05% | |
| 116 | GLUEMONTE ROSA THERAPEUTICS INC | 27,369 | $208.3M | 3.98% |
PreviousPage 2 of 2